Summary: The White House fully supports a robust review of the ethical issues associated with using gene-editing technology to alter the human germline
Last week, the National Academy of Sciences (NAS) and its National Academy of Medicine (NAM) announced that they will convene an international meeting this fall at which researchers, ethicists, and other experts will discuss the implications of human germline gene-editing technologies in both research and clinical applications
The White House applauds NAS and NAM for convening this dialogue and fully supports a robust review of the ethical issues associated with using gene-editing technology to alter the human germline
For example, researchers in China recently conducted genome-editing experiments in human embryos of a kind not able to develop into a fetus or a person
